Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC

Leona L. Pott(University of Duisburg-Essen), Hideo A. Baba(University of Duisburg-Essen)
Oncotarget
January 2, 2017
Cited by 42


Related Papers